1. Home
  2. WFCF vs TCRX Comparison

WFCF vs TCRX Comparison

Compare WFCF & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$12.50

Market Cap

61.5M

Sector

Technology

ML Signal

N/A

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

N/A

Current Price

$0.78

Market Cap

49.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFCF
TCRX
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.5M
49.4M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
WFCF
TCRX
Price
$12.50
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
4.3K
470.5K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.28
EPS
0.10
N/A
Revenue
$20,774,416.00
$10,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.81
P/E Ratio
$133.10
N/A
Revenue Growth
16.69
266.65
52 Week Low
$9.15
$0.72
52 Week High
$22.15
$2.57

Technical Indicators

Market Signals
Indicator
WFCF
TCRX
Relative Strength Index (RSI) 50.96 44.78
Support Level $12.01 $0.73
Resistance Level $13.27 $0.80
Average True Range (ATR) 0.63 0.04
MACD 0.05 0.01
Stochastic Oscillator 25.21 50.25

Price Performance

Historical Comparison
WFCF
TCRX

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: